Director/PDMR Shareholding

| Filed in:
Tate & Lyle PLC (“the Company”) was informed on 2 March 2006 that on 2 March 2006 the following share transactions were completed by Mr Robert Gibber, the Company Secretary and General Counsel and a Person Discharging Managerial Responsibility in the Company. i) Mr Gibber exercised options over ordinary shares in the Company under the Tate & Lyle 1992 Executive Share Option Scheme as follows: - options over 4,750 ordinary shares at 483 pence per share; and - options over 5,000 ordinary shares at 470.5 pence per share. ii) Mr Gibber exercised options over ordinary shares in the Company under the Tate & Lyle 2000 Executive Share Option Scheme as follows: - options over 59,440 ordinary shares at 374.5 pence per share. He subsequently sold 56,000 ordinary shares at 601.95 pence per share to pay the acquisition costs, tax and National Insurance, and retained 13,190 ordinary shares. Following this transaction, Mr Gibber now has an interest in 34,692 shares in the Company. The notification of these transactions is intended to satisfy the Company’s obligations under both section 324 Companies Act 1985 and Disclosure Rule 3.1.2.

Click here for our press image gallery

About Tate & Lyle: 
Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings. Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

We have around 4,400 employees working in more than 60 locations across 30 countries. Tate & Lyle’s purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2021, Tate & Lyle sales totalled £2.8 billion. For more information, please visit or follow Tate & Lyle on TwitterLinkedin or Facebook.